ClinicalTrials.Veeva

Menu

Using Large-area Low-level Light Therapy for Treating Adhesive Capsulitis of the Shoulder

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

Adhesive Capsulitis of Shoulder

Treatments

Device: Low-level laser therapy (LLLT)
Other: Conventional physical therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT06004609
202209047DIPA

Details and patient eligibility

About

Adhesive capsulitis, is a common problem characterized by the insidious onset of glenohumeral pain and limitation of shoulder motion in all planes. Clinically, frozen shoulder could be divided into freezing, frozen and thawing stage. The treatments of frozen shoulder are mainly conservative, including non-steroidal anti-inflammatory medications and physiotherapy. Due to debilitating pain at a certain stage and protracted clinical course, intra-articular corticosteroid injection in the early stages of idiopathic adhesive capsulitis has long been used to treat adhesive capsulitis with satisfactory result. However, intra-articular steroid injection still raise some controversy and is still considered too invasive for some patients.

Low-level laser therapy (LLLT) is a safe and non-invasive alternative. LLLT can employ photo-biomodulation effects to help normalize cellular functions and is considered to have partial effect in many shoulder soft tissue disorders. Possible mechanisms include increasing adenosine triphosphate production, fibroblast activity and collagen synthesis. One prospective cohort study has shown that LLLT can be effective in the management of the early phase (less than 6 weeks of disease onset) of adhesive capsulitis of the shoulder in elderly who failed to respond to conventional physical therapy and nonsteroidal anti-inflammatory medications and improvement was found maintained up to 2 years.

To this date, no randomized controlled study has been made to establish the possible role of LLLT as an adjuvant therapy on adhesive capsulitis. Also, no study has researched the effect of LLLT on patient with later stage/chronic phase of adhesive capsulitis. The objective of this paper is to report the clinical result of a study on the efficacy of LLLT as an add-on therapy in the management of adhesive capsulitis.

Enrollment

50 estimated patients

Sex

All

Ages

40 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 40 to 85 years old
  • Diagnosed with adhesive capsulitis clinically. Painful restriction of both active and passive flexion less than 120° and 50% restriction of the external rotation aside the body
  • Visual analog scale of shoulder motion pain greater than 3 on a scale of 10
  • No fracture, dislocation, or arthritis in shoulder region

Exclusion criteria

  • History of or scheduled shoulder or chest surgery

  • Significant shoulder trauma within the previous 2 years

  • Presence of cervical radiculopathy or other central or peripheral neurologic deficits of the upper limb

  • Known shoulder tendon tear or active tendinitis or bursitis as confirmed with US

  • Contraindication of low-level light therapy

    1. Pregnancy, cancer, patient with pacemaker, high bleeding tendency, or longterm corticosteroid use.
    2. Poor consciousness state, or patients with sensory impairment
    3. Patients hypersensitive to light
    4. Severe circulatory system disorder

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

50 participants in 2 patient groups

Treatment group (low-level laser therapy with conventional physical therapy)
Experimental group
Description:
Low-level laser therapy two to three times a week, 10 minutes each time, totally 24 times, for 8 to 10 weeks. Along with conventional physical therapy, two to three times a week, for 12 to 14 weeks.
Treatment:
Other: Conventional physical therapy
Device: Low-level laser therapy (LLLT)
Conventional group (conventional physical therapy only)
Active Comparator group
Description:
Conventional physical therapy, two to three times a week, for 12 to 14 weeks.
Treatment:
Other: Conventional physical therapy

Trial contacts and locations

1

Loading...

Central trial contact

En Yang, MD; Chueh-Hung Wu, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems